Dr Saligrama A Ranganath, MD | |
1251 Eastport Centre Dr Ste B, Valparaiso, IN 46383-2904 | |
(219) 462-9205 | |
(219) 462-9526 |
Full Name | Dr Saligrama A Ranganath |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 1251 Eastport Centre Dr Ste B, Valparaiso, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104263227 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 01040697A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Saligrama A Ranganath, MD 1251 Eastport Centre Dr Ste B, Valparaiso, IN 46383-2904 Ph: (219) 462-9205 | Dr Saligrama A Ranganath, MD 1251 Eastport Centre Dr Ste B, Valparaiso, IN 46383-2904 Ph: (219) 462-9205 |
News Archive
UCSF scientists have identified patterns of brain activity in the rat brain that play a role in the formation and recall of memories and decision-making. The discovery, which builds on the team's previous findings, offers a path for studying learning, decision-making and post-traumatic stress syndrome.
In research published in Cancer Cell, Thomas Burris, Ph.D., chair of pharmacology and physiology at Saint Louis University, has, for the first time, found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
The first European standards for the management of heart attack patients are launched today by the European Society of Cardiology-Acute Cardiac Care Association.
An international research team led by Queen's University have developed a ground breaking treatment for Cystic Fibrosis sufferers. The new drug will benefit sufferers who have the 'Celtic Gene', a genetic mutation which is particularly common in Ireland.
› Verified 1 days ago